Articles Tagged With: Dementia
-
Ethics of 10-Year Research Agenda for Dementia, Alzheimer’s Studies
There is a pressing need for more research on non-cure-based treatments for people living with dementia. That gap in is a real ethical concern. Social-behavioral research can help family members who are struggling to figure out where the loved one with dementia is going to live.
-
Case Managers Can Use 6 Interventions to Help Patients with Dementia
Recent research suggests new transitional care interventions are needed to improve physical and mental functioning after discharge for patients with dementia. Physical interventions target orthostatic tolerance, ambulation, and activities of daily living while cognitive interventions target sensory intervention, sleep, and communication. -
Statins, Cognitive Decline, and Dementia
An analysis of the ASPREE database showed that with almost five years of follow-up, statins are not associated with cognitive decline or dementia in a large group of elderly subjects in whom multiple tests of cognition were performed serially.
-
Anticholinergic Use for Three Months or More Increases Dementia Risk
There is a significant increase in dementia risk associated with the use of anticholinergic medications for three months or longer. -
Underrepresented Groups in Alzheimer’s Trials Remain Persistent Ethical Concern
Despite ongoing efforts to address disparities in Alzheimer’s disease and dementia care, much work remains. The authors of a recent report identified some of the barriers diverse populations are facing in accessing and receiving dementia care. -
Statins, Cognitive Decline, and Dementia
An analysis of the ASPREE database showed that with almost five years of follow-up, statins are not associated with cognitive decline or dementia in a large group of elderly subjects in whom multiple tests of cognition were performed serially. -
Long-Term Effects of Cholinesterase Inhibitors on Cognitive Decline, Mortality
Cholinesterase inhibitors are one of the few drug classes approved by the FDA to treat patients with Alzheimer’s disease. This study shows a long-term benefit in slowing the decline of cognition, but it is unclear if there is any benefit in quality of life. -
Researchers Observe No Connections Between Statin Therapy, Cognitive Decline
But randomized trials are needed to better detail long-term risk-benefit ratio. -
Helping Patients with Alzheimer’s Disease and Dementia
Regardless of whether they realize it, case managers have likely worked with patients who are living with Alzheimer’s disease or dementia. The diagnosis rate is relatively low. Even when a formal diagnosis is made, treatment is not necessarily offered — and for many patients, the diagnosis largely is overlooked. -
Anticholinergic Use for Three Months or More Increases Dementia Risk
There is a significant increase in dementia risk associated with the use of anticholinergic medications for three months or longer.